Larson Financial Group’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.3K | Sell |
290
-96
| -25% | -$6.71K | ﹤0.01% | 1478 |
|
|
2025
Q1 | $28.4K | Buy |
386
+289
| +298% | +$21.2K | ﹤0.01% | 1222 |
|
|
2024
Q4 | $6.34K | Sell |
97
-29
| -23% | -$1.9K | ﹤0.01% | 1602 |
|
|
2024
Q3 | $9.79K | Buy |
126
+19
| +18% | +$1.48K | ﹤0.01% | 1476 |
|
|
2024
Q2 | $8.31K | Buy |
107
+80
| +296% | +$6.22K | ﹤0.01% | 1309 |
|
|
2024
Q1 | $1.8K | Buy |
27
+1
| +4% | +$67 | ﹤0.01% | 1369 |
|
|
2023
Q4 | $1.78K | Sell |
26
-74
| -74% | -$5.07K | ﹤0.01% | 1381 |
|
|
2023
Q3 | $6.8K | Buy |
100
+74
| +285% | +$5.03K | ﹤0.01% | 1102 |
|
|
2023
Q2 | $1.89K | Sell |
26
-256
| -91% | -$18.6K | ﹤0.01% | 1274 |
|
|
2023
Q1 | $19.6K | Buy |
282
+256
| +985% | +$17.8K | ﹤0.01% | 742 |
|
|
2022
Q4 | $1.77K | Hold |
26
| – | – | ﹤0.01% | 1213 |
|
|
2022
Q3 | $1K | Hold |
26
| – | – | ﹤0.01% | 1171 |
|
|
2022
Q2 | $2K | Buy |
26
+7
| +37% | +$538 | ﹤0.01% | 1007 |
|
|
2022
Q1 | $1K | Sell |
19
-25
| -57% | -$1.32K | ﹤0.01% | 949 |
|
|
2021
Q4 | $3K | Hold |
44
| – | – | ﹤0.01% | 887 |
|
|
2021
Q3 | $3K | Buy |
44
+1
| +2% | +$68 | ﹤0.01% | 735 |
|
|
2021
Q2 | $3K | Hold |
43
| – | – | ﹤0.01% | 676 |
|
|
2021
Q1 | $2K | Hold |
43
| – | – | ﹤0.01% | 695 |
|
|
2020
Q4 | $2K | Sell |
43
-32
| -43% | -$1.49K | ﹤0.01% | 621 |
|
|
2020
Q3 | $4K | Buy |
+75
| New | +$4K | ﹤0.01% | 538 |
|